KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Sarepta Therapeutics (SRPT) over the last 15 years, with Q3 2025 value amounting to 0.31.

  • Sarepta Therapeutics' Debt Ratio fell 1008.18% to 0.31 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31, marking a year-over-year decrease of 1008.18%. This contributed to the annual value of 0.29 for FY2024, which is 2433.91% down from last year.
  • As of Q3 2025, Sarepta Therapeutics' Debt Ratio stood at 0.31, which was down 1008.18% from 0.31 recorded in Q2 2025.
  • In the past 5 years, Sarepta Therapeutics' Debt Ratio registered a high of 0.49 during Q4 2022, and its lowest value of 0.29 during Q4 2024.
  • Moreover, its 5-year median value for Debt Ratio was 0.38 (2023), whereas its average is 0.38.
  • Its Debt Ratio has fluctuated over the past 5 years, first soared by 6905.01% in 2021, then plummeted by 2433.91% in 2024.
  • Sarepta Therapeutics' Debt Ratio (Quarter) stood at 0.35 in 2021, then skyrocketed by 41.67% to 0.49 in 2022, then decreased by 23.18% to 0.38 in 2023, then dropped by 24.34% to 0.29 in 2024, then grew by 6.86% to 0.31 in 2025.
  • Its Debt Ratio was 0.31 in Q3 2025, compared to 0.31 in Q2 2025 and 0.33 in Q1 2025.